Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
International Journal of Cancer
|
September 27, 2021
Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
Sandra Karanović, Maude Ardin, Zuojian Tang, et al.
Head & Neck
|
May 4, 2026
Impact of Smoking on Treatment Outcomes in Patients With Human Papillomavirus-Related Oropharyngeal Cancer
Michelle M Kwan, Latifa A Bazzi, Zequn Sun, et al.
The Lancet. Oncology
|
September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L Kaufman, Jeffery Russell, Omid Hamid, et al.
Journal of the Endocrine Society
|
April 10, 2019
The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer
Nathalie Silva de Morais, Jessica Stuart, Haixia Guan, et al.
Oral Oncology
|
March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
Glenn J Hanna, Hongye Liu, Robert E Jones, et al.
JCO Precision Oncology
|
September 8, 2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer
Julia Schiantarelli, Theodora Pappa, Jake Conway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2016
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
Nicole G Chau, Yvonne Y Li, Vickie Y Jo, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
February 29, 2000
Current practice of temporary vena cava filter insertion: a multicenter registry
H Lorch, D Welger, V Wagner, et al.
JAMA Oncology
|
October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Glenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
International Journal of Cancer
|
September 27, 2021
Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
Sandra Karanović, Maude Ardin, Zuojian Tang, et al.
Head & Neck
|
May 4, 2026
Impact of Smoking on Treatment Outcomes in Patients With Human Papillomavirus-Related Oropharyngeal Cancer
Michelle M Kwan, Latifa A Bazzi, Zequn Sun, et al.
The Lancet. Oncology
|
September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L Kaufman, Jeffery Russell, Omid Hamid, et al.
Journal of the Endocrine Society
|
April 10, 2019
The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer
Nathalie Silva de Morais, Jessica Stuart, Haixia Guan, et al.
Oral Oncology
|
March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
Glenn J Hanna, Hongye Liu, Robert E Jones, et al.
JCO Precision Oncology
|
September 8, 2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer
Julia Schiantarelli, Theodora Pappa, Jake Conway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2016
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
Nicole G Chau, Yvonne Y Li, Vickie Y Jo, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
February 29, 2000
Current practice of temporary vena cava filter insertion: a multicenter registry
H Lorch, D Welger, V Wagner, et al.
JAMA Oncology
|
October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Glenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Page
of 9